Investing

Proceeds from Sale of Other Investments

Abbott Proceeds from Sale of Other Investments remained flat by 0.0% to $750.00K in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 89.3%, from $7.00M to $750.00K. Over 4 years (FY 2021 to FY 2025), Proceeds from Sale of Other Investments shows a downward trend with a -55.6% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
First reportedQ1 2020
Last reportedQ4 2025Feb 20, 2026
Metric ID: tmo_proceeds_from_sale_of_other_investments

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$77.00M$152.00M$43.00M$28.00M$3.00M
YoY Change—+97.4%-71.7%-34.9%-89.3%
Range$3.00M – $152.00M
CAGR-55.6%
Avg YoY Growth-24.6%
Median YoY Growth-53.3%
Current Streak3 years decline

Frequently Asked Questions

What is Abbott's proceeds from sale of other investments?
Abbott (ABT) reported proceeds from sale of other investments of $750.00K in Q4 2025.
How has Abbott's proceeds from sale of other investments changed year-over-year?
Abbott's proceeds from sale of other investments decreased by 89.3% year-over-year, from $7.00M to $750.00K.
What is the long-term trend for Abbott's proceeds from sale of other investments?
Over 4 years (2021 to 2025), Abbott's proceeds from sale of other investments has grown at a -55.6% compound annual growth rate (CAGR), from $77.00M to $3.00M.